Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20000 participants
OBSERVATIONAL
2024-10-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study is non-interventional and does not involve any interventions in clinical practice, the choice of treatment methods (including the type of medical device used and the method of surgical intervention) and examination.
A control observation group is not intended.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Failure Patients Registry
NCT04709263
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
NCT06114498
China National Heart Failure Registry
NCT02079428
Cardiometabolic evalUation REgistry of Heart Failure
NCT06939985
The First Russian Observational Survey of Heart Failure Patients With Atrial Fibrillation
NCT02790801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The duration of the observation period of an individual patient with CHF is limited by the study period, or the patient's death, and includes the studied retrospective and dynamic prospective parameters. Prospective data of CHF (any stage and FC) subjects are planned to be included sequentially as they appear in inpatient CHF centers and outpatient CHF offices until 12/31/2027 inclusive and further upon extension of the study.
Retrospective data will be provided by chief freelance cardiologists of 33 constituent entities of the Russian Federation (Central Federal District, Ural Federal District, Siberian Federal District, Far Eastern Federal District) (individually, according to agreement)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sergey A Boytsov, Prof.
Role: STUDY_CHAIR
E.I.Chazov Cardiology Center
Zoya N Blankova, MD, PhD
Role: STUDY_DIRECTOR
E.I.Chazov Cardiology Center
Fail' T Ageev, Prof.
Role: PRINCIPAL_INVESTIGATOR
E.I.Chazov Cardiology Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Organization
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ХОСТА ХСН
Identifier Type: OTHER
Identifier Source: secondary_id
HOSTa CHF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.